Ozempic has gotten most of the name recognition associated with weight-loss drugs, it's not the only drug in this category ...
Novo's lead drug is semaglutide, a glucagon-line peptide-1 (GLP-1) agonist that the Food and Drug Administration (FDA) approved as Ozempic and Rybelsus to treat diabetes and later as Wegovy to treat ...